Eric Deutsch, Chairman of Radiation Oncology at Institut Gustave Roussy, shared on LinkedIn:
“What a week in New York!
The 10th edition of ImmunoRad brought together an outstanding international community to explore how radiation oncology is evolving at the interface of immunology, systemic therapies and technology.
We had the privilege of hearing from Silvia Formenti, Jedd Wolchok, Ralph Weichselbaum, Sandra Demaria, Lorenzo Galluzzi, Andy Minn, James Welsh, Julie Blander, Zachary Morris, Anna Wu, Gabriela Kramer-Marek, Arta Monjazeb, Constantinos Koumenis, Sana Karam and many others.
And the science is expanding fast: RT + immunotherapy, theranostics and radiopharmaceuticals, immunoPET, thymic health and immune fitness, lymphocyte-sparing RT, FLASH, microbiome, cell therapy, spatial biomarkers and AI.
A huge thank you to all our speakers, chairs, young investigators and participants, and to our industry partners and contributors, including Ankyra Therapeutics, ZEISS and OncAI, for making this meeting possible.
Now, from New York to Paris
ImmunoRad Paris 2027
October 7–9, 2027
Our ambition is simple: bring an even broader community together across radiation oncology, immunology, medical oncology, nuclear medicine, theranostics, biotechnology, physics and AI.
If you are developing new science, a drug, a radiopharmaceutical, a technology or a clinical trial at these interfaces, we want you in Paris.
Come to present your work.
Come to challenge ours.
Come to find your next collaborators.
Save the date and join us in Paris!”
Other posts featuring Eric Deutsch on OncoDaily.